YHLO

2019-07-10

Summary:





YHLO will participate in the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim on August 6-8, which is one of the world’s largest exhibition of clinical lab professionals from around the world. You are welcome to visit our booth #3813. Our team is looking forward to see you there!

As an immunoassay solutions provider, YHLO never stops its effort to meet laboratory requirements all over the world. In this AACC, we will exibit iFlash 1800 CLIA analyzer and iModule system. With up to 112 CLIA parameters including autoimmunity, reproductive health, infectious disease and diabetes, the iFlash series are designed for various medical conditions.

More solutions and test panels will be exhibited. You’re welcome to schedule an appointment with us in advance.

Previous: YHLO at AACC 2019: Showing immunoassay and beyond

Next: YHLO Showcased Total Immunoasay Solutions in CMEF Shanghai

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +